- Home
- NX vs PRME Comparison
NX vs PRME Comparison
Compare NX & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NX | PRME |
|---|---|---|
| Founded | 1927 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 742.7M | 666.1M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | NX | PRME |
|---|---|---|
| Price | $15.61 | $3.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $28.00 | $6.42 |
| AVG Volume (30 Days) | 1.2M | ★ 3.8M |
| Earning Date | 12-11-2025 | 11-07-2025 |
| Dividend Yield | ★ 2.08% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,837,641,000.00 | $5,977,000.00 |
| Revenue This Year | $3.18 | $111.80 |
| Revenue Next Year | $2.27 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 43.81 | ★ 647.13 |
| 52 Week Low | $11.04 | $1.11 |
| 52 Week High | $24.79 | $6.94 |
Technical Indicators
Market Signals| Indicator | NX | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 58.52 | 40.04 |
| Support Level | $15.35 | $3.29 |
| Resistance Level | $15.65 | $4.12 |
| Average True Range (ATR) | 0.86 | 0.24 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 16.90 | 13.51 |
Price Performance
Historical ComparisonAbout NX Quanex Building Products Corporation
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.